On the limitations of causal inference with current-treatment Cox models
仅含当前治疗的 Cox 模型在因果推断中的局限AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要直接讨论时变治疗、边际结构 Cox 模型和干预特定生存概率的因果解释及识别限制。
仅含当前治疗的 Cox 模型在因果推断中的局限AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
Cox models with time-varying treatments often include only the current treatment level. Translating such a model into causally meaningful intervention-specific survival probabilities relies on the Markov property: that the hazard is independent of treatment history conditional on current treatment. For the Markov property to not be population-specific, it needs to hold also conditional on any unmeasured prognostic heterogeneity (frailty). Using a discrete-time argument, earlier work concluded that the Markov property can hold both conditionally and marginally only in the absence of a treatment effect or an effect of the unmeasured heterogeneity. We broaden this argument by developing a continuous-time framework that encompasses both proposed extensions of the Kaplan-Meier curve and current-treatment marginal structural Cox models, and sharpen it by characterizing precisely the conditions under which the Markov property can hold both conditionally and marginally. Specifically, we show that it requires the absence of treatment-frailty interaction on the additive hazard scale. As frailty is inherently unmeasured, such a no-interaction assumption cannot be verified. Consequently, causal interpretation of a current-treatment marginal structural Cox model rests on a strong and unverifiable structural assumption. Illustrating this point, we construct a setting in which a Cox model is correctly specified conditionally on current treatment only, although the marginal Markov property fails. Transforming the fitted model to the survival scale does not recover the true intervention-specific survival probabilities. Thus, moving from the hazard scale to the survival scale is not in itself sufficient to obtain a causal interpretation in the time-varying treatment setting.